Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017
"Ovarian
Cancer - Treatment Landscape & Competitive Analysis, 2017"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
DelveInsights,
Ovarian Cancer - Treatment Landscape & Competitive Analysis,
2017, report provides comprehensive insights about the treatment
landscape across this indication. This report also provides the deep
understanding of the stages of the ovarian cancer, epidemiology, risk
factors, diagnosis etc. A key objective of the report is to establish
the understanding of the treatment landscape and competitive analysis
of the Ovarian Cancer which mainly describes the treatment of ovarian
cancer at different stages.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1009113
Ovarian
cancer is the sudden growth of the cells in the ovary and is a type
of cancer that affects females only. The cancer forms in tissues of
the ovary when normal cells are affected. It can affect either one or
both the ovaries. It is estimated that every year approximately
21,000 women in USA and 5,500 women in UK are diagnosed with ovarian
cancer. It is the eighth most common cancer among women in USA and
fifth most common cancer among females in UK. This report provides
the insights of the marketed drugs for the Ovarian Cancer which
includes the Targeted Therapy and Chemotherapy. These days companies
are focusing on the Targeted Therapy for cancer. Many big
pharmaceuticals companies are involved in ovarian cancer with their
preregistration products. Cediranib of AstraZeneca and Paclitaxel of
Oasmia Pharmaceutical AB is ready to hit the market in few coming
years. All are in preregistration stage. Along with the Targeted
Therapy, this report also provides the landscape of Chemotherapy
available for the Ovarian Cancer. This report also covers the
comparison of the Targeted Therapy and Chemotherapy which provides
the insights for the marketed drugs. Analysis of the marketed drugs
provides the understanding of cost of treatment, therapeutic class,
patent expiry and sales data of the drugs. Recent report of
DelveInsight covers the treatment landscape which provides the
treatment options by different stages of the ovarian cancer.
Currently the treatment is divided into the Targeted therapy and
Chemotherapy. There are two products under Targeted therapy and seven
products under Chemotherapy.
Note: This report will be delivered to the client in 1-2 business days
** Report Highlights:
The new report, provides a Ovarian Cancer Treatment Landscape across the globe
The report provides profiles of the marketed drug which includes the product description, cost of treatment, development partner, patent expiry date, sales data etc.
Comparative analysis of marketed drugs by therapy, cost of treatment and Therapeutic Class.
Coverage of the Ovarian Cancer Phase III and Pre-registration Drugs Analysis by product type, molecule type, route of administration, Median Progression Free Survival
Note: This report will be delivered to the client in 1-2 business days
** Report Highlights:
The new report, provides a Ovarian Cancer Treatment Landscape across the globe
The report provides profiles of the marketed drug which includes the product description, cost of treatment, development partner, patent expiry date, sales data etc.
Comparative analysis of marketed drugs by therapy, cost of treatment and Therapeutic Class.
Coverage of the Ovarian Cancer Phase III and Pre-registration Drugs Analysis by product type, molecule type, route of administration, Median Progression Free Survival
The report reviews key players involved in the therapeutics development for Ovarian Cancer and also provide market barriers, market drivers and opportunities
Provides Phase III products assessment by monotherapy and combination therapy products, and molecule type.
Introduction
Disease Introduction
Stages of Ovarian Cancer
Treatment Options
Ovarian Cancer Treatment Timeline
Pathophysiology
Epidemiology
Etiology
Symptoms
Risk Factors
Diagnosis
Pathology
Treatment Landscape
Treatment Options by Stage
Stage IA
Stage IB
Stage IC
Stage IIA
Stage IIB, Stage IIC, Stage IIIA, Stage, IIIB, Stage IIIC, Stage IV
Treatment Algorithm
Treatment Follow-Up
Chemotherapy Regimens
Ovarian Cancer: Marketed Products
Targeted Therapy
Drug 1 - Product Profile
Drug Description
Advantages & Disadvantages
Product Profile
Side Effects
Historical Global Sales Data
Chemotherapy
Drug 2- Product Profile
Drug Description
Advantages and Disadvantages
Product Profile
Side Effects
Ovarian Cancer Marketed Drugs Analysis
Marketed Drugs Analysis- By Type of Therapy
Targeted therapy vs. chemotherapy
Marketed Drugs Analysis- Patent Expiry and Drug Sales
Marketed Drugs Analysis - Cost of Treatment
Current Unmet Needs for Ovarian Cancer Treatment
Ovarian Cancer Phase III and Pre-registration Drugs Analysis
Phase III and Pre-registration Drugs Analysis- By Product Type
Phase III Drugs and Pre-registration Analysis-By Line of Therapy
Phase III Drugs and Pre-registration Analysis- By Molecule Type
Phase III Drugs and Pre-registration Analysis- By Route of Administration
Phase III Drugs and Pre-registration Analysis- By Target
Phase III Drugs and Pre-registration Analysis- Median Progression Free Survival
Phase III Drugs and Pre-registration Analysis- Designation
Pipeline Product Analysis
Filing Withdrawn drug analysis
Ovarian Cancer Market Characterization
Market Drivers
Market Barriers
Market Opportunities
Appendix
Methodology
Disease Introduction
Stages of Ovarian Cancer
Treatment Options
Ovarian Cancer Treatment Timeline
Pathophysiology
Epidemiology
Etiology
Symptoms
Risk Factors
Diagnosis
Pathology
Treatment Landscape
Treatment Options by Stage
Stage IA
Stage IB
Stage IC
Stage IIA
Stage IIB, Stage IIC, Stage IIIA, Stage, IIIB, Stage IIIC, Stage IV
Treatment Algorithm
Treatment Follow-Up
Chemotherapy Regimens
Ovarian Cancer: Marketed Products
Targeted Therapy
Drug 1 - Product Profile
Drug Description
Advantages & Disadvantages
Product Profile
Side Effects
Historical Global Sales Data
Chemotherapy
Drug 2- Product Profile
Drug Description
Advantages and Disadvantages
Product Profile
Side Effects
Ovarian Cancer Marketed Drugs Analysis
Marketed Drugs Analysis- By Type of Therapy
Targeted therapy vs. chemotherapy
Marketed Drugs Analysis- Patent Expiry and Drug Sales
Marketed Drugs Analysis - Cost of Treatment
Current Unmet Needs for Ovarian Cancer Treatment
Ovarian Cancer Phase III and Pre-registration Drugs Analysis
Phase III and Pre-registration Drugs Analysis- By Product Type
Phase III Drugs and Pre-registration Analysis-By Line of Therapy
Phase III Drugs and Pre-registration Analysis- By Molecule Type
Phase III Drugs and Pre-registration Analysis- By Route of Administration
Phase III Drugs and Pre-registration Analysis- By Target
Phase III Drugs and Pre-registration Analysis- Median Progression Free Survival
Phase III Drugs and Pre-registration Analysis- Designation
Pipeline Product Analysis
Filing Withdrawn drug analysis
Ovarian Cancer Market Characterization
Market Drivers
Market Barriers
Market Opportunities
Appendix
Methodology
Comments
Post a Comment